Medicine is no place to cut corners

The American medical system is a far cry from true laissez-faire economics, but free-market bright spots certainly exist. Efforts to elevate health savings accounts and expand direct primary care are helping patients sidestep the quasi-government maze Obamacare helped to create. Private drugmakers, meanwhile, continue to push the boundaries of medicine.

Personalized vaccines to prevent skin cancer are showing promise. Other companies are making breakthroughs in lung disease research, and artificial intelligence is quickening oncology innovations. Obesity rates are finally declining as GLP-1 makers compete for market share, a dynamic that renders treatments more accessible and affordable.